IKNK.U Stock Overview
Operates as an integrated cannabis cultivator, producer, distributor, and dispensary operator in California and Colombia.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Pideka Group Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.22 |
52 Week High | US$0 |
52 Week Low | US$0 |
Beta | 0 |
1 Month Change | 0% |
3 Month Change | 877.78% |
1 Year Change | n/a |
3 Year Change | -79.05% |
5 Year Change | n/a |
Change since IPO | -78.00% |
Recent News & Updates
Recent updates
Shareholder Returns
IKNK.U | CA Pharmaceuticals | CA Market | |
---|---|---|---|
7D | 0% | 1.7% | 1.1% |
1Y | n/a | 64.6% | 10.8% |
Return vs Industry: Insufficient data to determine how IKNK.U performed against the Canadian Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how IKNK.U performed against the Canadian Market.
Price Volatility
IKNK.U volatility | |
---|---|
IKNK.U Average Weekly Movement | 179.8% |
Pharmaceuticals Industry Average Movement | 14.4% |
Market Average Movement | 8.9% |
10% most volatile stocks in CA Market | 17.8% |
10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: IKNK.U's share price has been volatile over the past 3 months.
Volatility Over Time: IKNK.U's weekly volatility has increased from 122% to 180% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Borja Sanz De Madrid | www.iknkbrands.com |
Pideka Group Inc. operates as an integrated cannabis cultivator, producer, distributor, and dispensary operator in California and Colombia. The company offers pharmaceutical grade cannabinoids, decarboxylated flower, finished CBD products, and finished ingredient cannabis oil for scientific and commercial sales. It provides its products under the Ikanik, Essentials, Ronen, and Rations brands.
Pideka Group Inc. Fundamentals Summary
IKNK.U fundamental statistics | |
---|---|
Market cap | US$49.49m |
Earnings (TTM) | -US$15.91m |
Revenue (TTM) | US$1.94m |
0.0x
P/S Ratio0.0x
P/E RatioIs IKNK.U overvalued?
See Fair Value and valuation analysisEarnings & Revenue
IKNK.U income statement (TTM) | |
---|---|
Revenue | US$1.94m |
Cost of Revenue | US$1.77m |
Gross Profit | US$163.05k |
Other Expenses | US$16.07m |
Earnings | -US$15.91m |
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did IKNK.U perform over the long term?
See historical performance and comparison